Prospective, Randomized, Open-labelled and Blind Endpoint Study of EECP in patients with Coronary Artery Disease

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-08000239

Enrollment

Unknown

Registered

2008-12-16

Start date

2008-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Interventions

experimental group:EECP and standard therapy

control group:standard therapy

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. At least one more than 50% stenosis was shown by angiography; 2. history of AMI(at least one month before); 3. Prior PCI; 4. Typical angina episodes with evidence of myocardiam ischemia; 5. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Obvious aortic insufficiency, aortic aneurysm, aortic dissecion; 2. Coronary fistula or severe coronary aneurysm; 3. Congestive heart failure with symptoms; 4. Valve disease, congenital heart diseases, cardiomyopathy; 5. Cerebral bleeding within six months, bleeding diseases or identified bleeding tendency; 6. Lower limb infection, phlebitis, varicosity, deep venous thrombosis; 7. Progressive malignant tumor or diseases with poor prognosis; 8. SBP>=180mmHg or DBP>=110mmHg.

Design outcomes

Secondary

Measure	Time frame
diabetes;heart structure and exercise tolerance;24-hour urine protein;vessel endotheliun function;atherosclerosis;	—

Primary

Measure	Time frame
rehospitalized rate;morbidity of AMI;revasculation;survival rate;	—

Countries

China

Contacts

Public ContactDu Zhimin

gz.dzm@hotmail.com+86 0 13802505880

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026